Abel Murillo

658 total citations
2 papers, 24 citations indexed

About

Abel Murillo is a scholar working on Infectious Diseases, Hepatology and Genetics. According to data from OpenAlex, Abel Murillo has authored 2 papers receiving a total of 24 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Hepatology and 1 paper in Genetics. Recurrent topics in Abel Murillo's work include Hepatitis C virus research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Monoclonal and Polyclonal Antibodies Research (1 paper). Abel Murillo is often cited by papers focused on Hepatitis C virus research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Monoclonal and Polyclonal Antibodies Research (1 paper). Abel Murillo collaborates with scholars based in United States and France. Abel Murillo's co-authors include Daniel Gruener, Eric Lawitz, Bradley Vince, John M. Hill, Joseph McCarville, William O’Riordan, Jie Chen, J. Sullivan-Bolyai, Douglas L. Mayers and Lynn R. Webster and has published in prestigious journals such as Journal of Hepatology.

In The Last Decade

Abel Murillo

2 papers receiving 24 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abel Murillo United States	2	22	19	7	3	3	2	24
Farihah Malik United Kingdom	3	31 1.4×	30 1.6×	6 0.9×	3 1.0×		10	36
Abdel Karim Sermé Burkina Faso	4	15 0.7×	20 1.1×	4 0.6×	2 0.7×		15	30
R. Solá Spain	3	15 0.7×	20 1.1×	5 0.7×	2 0.7×		9	31
Hasnain Jafferbhoy United Kingdom	3	33 1.5×	33 1.7×	6 0.9×	2 0.7×		6	41
Markus Gess United Kingdom	3	13 0.6×	17 0.9×	8 1.1×	3 1.0×		4	25
Maria Cássia Mendes Corrêa Brazil	3	9 0.4×	14 0.7×	7 1.0×	3 1.0×		7	29
Charles Mbendi Nlombi Democratic Republic of the Congo	3	13 0.6×	18 0.9×	7 1.0×			4	31
Faisal Ismail Libya	4	16 0.7×	18 0.9×	8 1.1×			17	35
Bebi Yassin-Rajkumar Canada	3	14 0.6×	16 0.8×	7 1.0×			4	18
Will Rowe United Kingdom	2	14 0.6×	15 0.8×	5 0.7×			2	19

Countries citing papers authored by Abel Murillo

Since Specialization

Citations

This map shows the geographic impact of Abel Murillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel Murillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel Murillo more than expected).

Fields of papers citing papers by Abel Murillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abel Murillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel Murillo. The network helps show where Abel Murillo may publish in the future.

Co-authorship network of co-authors of Abel Murillo

This figure shows the co-authorship network connecting the top 25 collaborators of Abel Murillo. A scholar is included among the top collaborators of Abel Murillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abel Murillo. Abel Murillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Vince, Bradley, John M. Hill, Eric Lawitz, et al.. (2014). A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4. Journal of Hepatology. 60(5). 920–927. 19 indexed citations

2.

Lawitz, Eric, John M. Hill, Bradley Vince, et al.. (2013). 847 ACH-2684 DEMONSTRATES POTENT VIRAL SUPPRESSION IN GENOTYPE 1 HEPATITIS C PATIENTS WITH AND WITHOUT CIRRHOSIS: SAFETY, PHARMACOKINETIC, AND VIRAL KINETIC ANALYSIS. Journal of Hepatology. 58. S347–S347. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact